logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5655.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5655.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV

Bonnet MMB, Gabillard D, Domoua SK, Muzoora C, Messou E,  et al.
2023-03-08 • Clinical Infectious Diseases
2023-03-08 • Clinical Infectious Diseases
BACKGROUND
In people with HIV (PWH), the WHO-recommended tuberculosis four-symptom screen (W4SS) targeting those who need molecular rapid test may be suboptimal. We assessed the perf...
Conference Material
|
Poster
Conference Material
|
Poster
Journal Article
|
Research
Conference Material
|
Abstract
Journal Article
|
Research
Conference Material
|
Poster
Conference Material
|
Slide Presentation

Evaluation of the Optimising Malnutrition treatment (OptiMA) strategy amongst severely wasted children aged 6-59 months: randomized trial, Democratic Republic of Congo

Cazes C, Phelan KPQ, Hubert V, Boubacar H, Tshibangu G,  et al.
2021-05-18 • MSF Scientific Days International 2021: Research
2021-05-18 • MSF Scientific Days International 2021: Research

Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated kwashiorkor: a secondary analysis of the OptiMA-DRC trial

Cazes C, Sirna F, Phelan KPQ, Hubert V, Tshiala BK,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022

Systematic or test-guided treatment for tuberculosis in HIV-infected adults

Blanc FX, Badje AD, Bonnet MMB, Gabillard D, Messou E,  et al.
2020-06-18 • New England Journal of Medicine
2020-06-18 • New England Journal of Medicine
BACKGROUND
In regions with high burdens of tuberculosis and human immunodeficiency virus (HIV), many HIV-infected adults begin antiretroviral therapy (ART) when they are already seve...

Optimising malnutrition treatment in children 6-59 months: primary outcome of a randomized trial, Democratic Republic of Congo

Cazes C, Phelan KPQ, Hubert V, Boubacar H, Bozama LI,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
The Optimising MAlnutrition treatment (OptiMA) strategy aims to simplify current malnutrition treatment protocols for children with mid-upper arm circumference (MUAC)<12...

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O,  et al.
2013-04-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
2013-04-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness ...

Optimising acute malnutrition treatment is non-inferior to standard protocol in uncomplicated severely wasted children: main secondary outcome of a randomised controlled trial in Democratic Republic of Congo

Cazes C, Phelan KPQ, Hubert V, Boubacar H, Tshibangu G,  et al.
2021-05-18 • MSF Scientific Days International 2021: Research
2021-05-18 • MSF Scientific Days International 2021: Research

Optimising malnutrition treatment in children aged 6-59 months: ​Primary outcome of a randomised controlled trial in Democratic Republic of Congo​

Cazes C, Phelan KPQ, Hubert V, Boubacar H, Bozama LI,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research